keyword
https://read.qxmd.com/read/38638295/nutritional-support-therapy-for-liver-transplantation-in-an-adult-onset-type-ii-citrullinemia-patient-a-case-report
#1
Yao Du, Yang-Yang Fu, Yang Yue, Bing Han, Wen-Jie Zhang, De-Cai Yu, Xiao-Jie Bian
Liver transplantation is an effective measure to treat adult-onset type II citrullinemia (CTLN2). Active and effective perioperative nutrition support is a very important treatment for the prognosis of such patients. In this paper, we analyzed the process, results, and outcome of nutritional support therapy in a case of CTLN2, and concluded that the perioperative nutritional support program for CTLN2 patients should be followed prior to surgery:1.because of the prevalence of severe malnutrition in CTLN2 patients, Enteral nutrition (EN) combined with Parenteral nutrition (PN) should be the first choice for nutritional support; 2...
2024: Frontiers in Nutrition
https://read.qxmd.com/read/38610706/biological-therapy-for-psoriasis-in-cancer-patients-an-8-year-retrospective-real-life-study
#2
JOURNAL ARTICLE
Teresa Battista, Lucia Gallo, Fabrizio Martora, Davide Fattore, Luca Potestio, Sara Cacciapuoti, Massimiliano Scalvenzi, Matteo Megna
Background : It is now recognized that psoriasis plays a key role in the development of several comorbidities, such as cardiovascular disease, and metabolic syndrome. Some authors have hypothesized that patients with psoriasis may have an increased risk of developing certain types of cancer. The efficacy and safety of biologic drugs are well-documented in clinical trials and in real-life studies. However, there is limited evidence on the safety of the use of biologic treatments in cancer patients with psoriasis, and the use of this therapeutic class in patients with a pre-existing or concomitant malignancy is still debated...
March 27, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38559227/insulin-resistance-and-not-%C3%AE-cell-impairment-mediates-association-between-mycobacterium-tuberculosis-sensitization-and-type-ii-diabetes-mellitus-among-us-adults
#3
I M Magodoro, A Aluoch, B Claggett, M J Nyirenda, M J Siedner, K A Wilkinson, R J Wilkinson, Nab Ntusi
UNLABELLED: Type 2 diabetes mellitus (T2DM) may be a long-term sequela of infection with Mycobacterium tuberculosis (M.tb) by mechanisms that remain to be fully explained. We evaluated association between M.tb sensitization and T2DM among U.S adults and, via formal mediation analysis, the extent to which this association is mediated by insulin resistance and/or β-cell failure. These evaluations accounted for demographic, socio-economic, behavioral and clinical characteristics. T2DM was assessed by fasting plasma glucose, 2-hour oral glucose tolerance testing and HbA1c; homoeostasis model assessment 2 (HOMA2) was used to estimate β-cell dysfunction (HOMA2-B) and insulin resistance (HOMA2-IR); while M...
March 15, 2024: medRxiv
https://read.qxmd.com/read/38503330/clinical-landscape-of-citrin-deficiency-a-global-perspective-on-a-multifaceted-condition
#4
JOURNAL ARTICLE
Jun Kido, Georgios Makris, Saikat Santra, Johannes Häberle
Citrin deficiency is an autosomal recessive disorder caused by a defect of citrin resulting from mutations in SLC25A13. The clinical manifestation is very variable and comprises three types: neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD: OMIM 605814), post-NICCD including failure to thrive and dyslipidemia caused by citrin deficiency, and adult-onset type II citrullinemia (CTLN2: OMIM 603471). Frequently, NICCD can run with a mild clinical course and manifestations may resolve in the post-NICCD...
March 19, 2024: Journal of Inherited Metabolic Disease
https://read.qxmd.com/read/38490126/effect-of-denosumab-on-inflammation-and-bone-health-in-active-charcot-foot-a-phase-ii-randomised-controlled-trial
#5
JOURNAL ARTICLE
Joel Willem Johan Lasschuit, Jacqueline Ruth Center, Jerry Richard Greenfield, Katherine Thuy Trang Tonks
AIMS: We aimed to investigate the effect of denosumab on pedal bone health and clinical resolution in active Charcot foot (CN). METHODS: This multicentre open-label phase 2 randomised controlled trial recruited adults with diabetes mellitus and active CN within 3 months of onset. Participants were randomised to standard care alone, or with denosumab 60 mg subcutaneously. Denosumab was administered at baseline and again at 6 months, unless foot temperature had normalised (i...
March 5, 2024: Journal of Diabetes and its Complications
https://read.qxmd.com/read/38457969/dna-methylation-mediates-the-effects-of-pm-2-5-and-o-3-on-ceramide-metabolism-a-novel-mechanistic-link-between-air-pollution-and-insulin-resistance
#6
JOURNAL ARTICLE
Ke Zhang, Gongbo Chen, Jie He, Zhongyang Chen, Mengnan Pan, Jiahui Tong, Feifei Liu, Hao Xiang
Insulin resistance (IR), linked to air pollution, is an initial stage of early-onset Type 2 diabetes mellitus (T2DM). While ceramide metabolism plays an important role in IR pathogenesis, the effects of air pollution on this process and its mechanisms remain unclear. We recruited young adults aged 18-30 years to a panel study in Wuhan, China. Using personal portable devices and stationary monitoring stations, we tracked particulate matter with aerodynamic diameters≤ 2.5 µm (PM2.5 ) and Ozone (O3 ) levels...
February 22, 2024: Journal of Hazardous Materials
https://read.qxmd.com/read/38438279/melatonin-does-not-reduce-delirium-severity-in-hospitalized-older-adults-results-of-a-randomized-placebo-controlled-trial
#7
JOURNAL ARTICLE
Peter W Lange, Alisa Turbić, Cheng Hwee Soh, Daniel Clayton-Chubb, Wen Kwang Lim, Rachel Conyers, Rosie Watson, Andrea B Maier
BACKGROUND: Delirium is common in older inpatients, causing distress, cognitive decline, and death. Current therapies are unsatisfactory, limited by lack of efficacy and adverse effects. There is an urgent need for effective delirium treatment. Sleep wake cycle is disturbed in delirium; endogenous Melatonin is perturbed, and exogenous Melatonin is a safe and effective medication for sleep disorders. This study aims to determine the effect of oral Melatonin 5 mg immediate release (IR) nightly for five nights on the severity of delirium in older (≥65 years) medical inpatients...
March 4, 2024: Journal of the American Geriatrics Society
https://read.qxmd.com/read/38418563/104-week-efficacy-and-safety-of-cipaglucosidase-alfa-plus-miglustat-in-adults-with-late-onset-pompe-disease-a-phase-iii-open-label-extension-study-atb200-07
#8
JOURNAL ARTICLE
Benedikt Schoser, Priya S Kishnani, Drago Bratkovic, Barry J Byrne, Kristl G Claeys, Jordi Díaz-Manera, Pascal Laforêt, Mark Roberts, Antonio Toscano, Ans T van der Ploeg, Jeff Castelli, Mitchell Goldman, Fred Holdbrook, Sheela Sitaraman Das, Yasmine Wasfi, Tahseen Mozaffar
The phase III double-blind PROPEL study compared the novel two-component therapy cipaglucosidase alfa + miglustat (cipa + mig) with alglucosidase alfa + placebo (alg + pbo) in adults with late-onset Pompe disease (LOPD). This ongoing open-label extension (OLE; NCT04138277) evaluates long-term safety and efficacy of cipa + mig. Outcomes include 6-min walk distance (6MWD), forced vital capacity (FVC), creatine kinase (CK) and hexose tetrasaccharide (Hex4) levels, patient-reported outcomes and safety...
February 28, 2024: Journal of Neurology
https://read.qxmd.com/read/38410281/baseline-characteristics-of-fabry-disease-amenable-migalastat-patients-in-argentinian-cohort
#9
JOURNAL ARTICLE
Sebastián Jaurretche, Santiago Alonso, Mónica Calvo, Sebastián Fernandez, Heber Figueredo, Beatriz Galli, Ivanna Marin, Andrés Martinez, Silvia Mattausch, Fernando Perretta, Juan Politei, Juan Ignacio Rolon, Esteban Calabrese
Fabry disease (FD) is a multisystem lysosomal storage disorder induced by genetic variants in the alpha-galactosidase A ( α GalA) gene. Some FD patients have GLA variants with a reduction in overall α GalA enzymatic activity due to mutated proteins with reduced stability, caused by protein misfolding and premature degradation, but the α GalA catalytic activity remains conserved ("amenable" genetic variants). To correct this misfolding and to prevent premature degradation, migalastat, a small iminosugar molecule was developed...
2024: Global Health, Epidemiology and Genomics
https://read.qxmd.com/read/38304188/biology-ecology-and-biogeography-of-eremic-praying-mantis-blepharopsis-mendica-insecta-mantodea
#10
JOURNAL ARTICLE
Zohreh Mirzaee, Marianna V P Simões, Roberto Battiston, Saber Sadeghi, Martin Wiemers, Thomas Schmitt
BACKGROUND: Blepharopsis mendica (Fabricius, 1775) is a large mantid species found from the Canary Islands across North Africa, the Middle East, and Pakistan. Research on this species has been limited, especially in Iran, despite the country's potential significance for studying its biology and distribution. Adults of this species are easily recognizable by their marble-white pattern and rhomboidal leaf-like pronotum. They are sit-and-wait predators that inhabit various open environments...
2024: PeerJ
https://read.qxmd.com/read/38261315/evaluating-avalglucosidase-alfa-for-the-management-of-late-onset-pompe-disease
#11
REVIEW
Corrado Angelini
INTRODUCTION: Glycogenosis type II (GSDII) is a rare autosomal disorder that is caused by the deficiency of alpha-glucosidase, a lysosomal enzyme that hydrolyzes glycogen to glucose. Autophagy dysregulation plays a critical role. Importantly, since 2006, both patients with infantile (classic Pompe disease) and adult GSDII (late-onset Pompe disease or LOPD) have been treated with enzyme replacement therapy (ERT). To support this use, several double-blind and observational studies including large cohorts of GSDII patients have been undertaken and have shown ERT to be effective in modifying the natural course of disease...
March 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38186847/characterization-of-orthopedic-manifestations-in-patients-with-mucopolysaccharidosis-ii-using-data-from-15%C3%A2-years-of-the-hunter-outcome-survey
#12
JOURNAL ARTICLE
Bianca Link, Jaco Botha, Roberto Giugliani
Mucopolysaccharidosis II (MPS II) is a rare, life-limiting lysosomal storage disease caused by reduced iduronate-2-sulfatase activity. Patients experience broad ranging signs and symptoms, including bone and joint manifestations. This study reported on orthopedic involvement and management in patients with MPS II using 15 years of data from the Hunter Outcome Survey (HOS). Of the 245 patients in the study population, 90.2% had skeletal deformity (median onset, 2.8 years), 76.7% had upper body stiffness (onset, 4...
January 2024: JIMD Reports
https://read.qxmd.com/read/38165373/clinical-imaging-genetic-and-disease-course-characteristics-in-patients-with-gm2-gangliosidosis-beyond-age-of-onset
#13
MULTICENTER STUDY
Jan Kern, Judith Böhringer, Dagmar Timmann, Regina Trollmann, Claudia Stendel, Cristoph Kamm, Markus Röbl, Vidiyaah Santhanakumaran, Samuel Groeschel, Stefanie Beck-Wödl, Sophia Göricke, Ingeborg Krägeloh-Mann, Matthis Synofzik
BACKGROUND AND OBJECTIVES: GM2 gangliosidoses, a group of autosomal-recessive neurodegenerative lysosomal storage disorders, result from β-hexosaminidase (HEX) deficiency with GM2 ganglioside as its main substrate. Historically, GM2 gangliosidoses have been classified into infantile, juvenile, and late-onset forms. With disease-modifying treatment trials now on the horizon, a more fine-grained understanding of the disease course is needed. METHODS: We aimed to map and stratify the clinical course of GM2 gangliosidoses in a multicenter cohort of pediatric and adult patients...
January 9, 2024: Neurology
https://read.qxmd.com/read/38125745/focusing-on-colorectal-cancer-in-young-adults-review
#14
REVIEW
Virginia Constantinou, Constantina Constantinou
Colorectal cancer (CRC) ranks as the third leading cause of cancer-related mortality worldwide. Recent years have witnessed an increase in the incidence of CRC among adults <50 years old on a global scale. The increased incidence is associated with several modifiable risk factors, including obesity, type II diabetes, physical inactivity and frequent antibiotic use. In younger individuals, haematochezia and abdominal pain are the most common symptoms, predominantly affecting the left-side colon. While certain cases of early-onset CRC (eoCRC) are associated with a genetic predisposition, the majority result from sporadic mutations in the genes APC , KRAS , BRAF and TP53 , which trigger uncontrolled cell proliferation and tumour formation...
January 2024: Molecular and Clinical Oncology
https://read.qxmd.com/read/38097032/a-systematic-review-of-metabolomic-findings-in-adult-and-pediatric-renal-disease
#15
REVIEW
Lennart Moritz, Anke Schumann, Martin Pohl, Anna Köttgen, Luciana Hannibal, Ute Spiekerkoetter
Chronic kidney disease (CKD) affects over 0.5 billion people worldwide across their lifetimes. Despite a growingly ageing world population, an increase in all-age prevalence of kidney disease persists. Adult-onset forms of kidney disease often result from lifestyle-modifiable metabolic illnesses such as type 2 diabetes. Pediatric and adolescent forms of renal disease are primarily caused by morphological abnormalities of the kidney, as well as immunological, infectious and inherited metabolic disorders. Alterations in energy metabolism are observed in CKD of varying causes, albeit the molecular mechanisms underlying pathology are unclear...
December 12, 2023: Clinical Biochemistry
https://read.qxmd.com/read/37987015/entorhinal-cortex-vulnerability-to-human-app-expression-promotes-hyperexcitability-and-tau-pathology
#16
Matthew Rowan, Annie Goettemoeller, Emmie Banks, Katharine McCann, Prateek Kumar, Kelly South, Viktor Olah, Christina Ramelow, Duc Duong, Nicholas Seyfried, Srikant Rangaraju, David Weinshenker
Preventative treatment for Alzheimer's Disease is of dire importance, and yet, cellular mechanisms underlying early regional vulnerability in Alzheimer's Disease remain unknown. In human patients with Alzheimer's Disease, one of the earliest observed pathophysiological correlates to cognitive decline is hyperexcitability1. In mouse models, early hyperexcitability has been shown in the entorhinal cortex, the first cortical region impacted by Alzheimer's Disease2-4. The origin of hyperexcitability in early-stage disease and why it preferentially emerges in specific regions is unclear...
November 6, 2023: Research Square
https://read.qxmd.com/read/37964993/symptomatic-drug-resistant-narcolepsy-remission-after-fenestration-of-an-arachnoid-cyst-a-case-report
#17
Erika C S Künstler, Matthias Schwab, Henry W S Schroeder, Sven Rupprecht
OBJECTIVE: The pathogenesis of different narcolepsy phenotypes remains unclear. In rare cases, narcolepsy can be attributable to secondary brain pathologies affecting the midbrain. These cases may elucidate the pathological background and the treatment of narcolepsy, but are often limited by poor objective symptom characterization and effects of therapeutic intervention, especially by modern diagnostic standards. METHODS: A young adult presented with excessive daytime sleepiness (EDS) that was refractory to classic narcolepsy medication...
2023: Nature and Science of Sleep
https://read.qxmd.com/read/37933340/myopathic-carnitine-palmitoyltransferase-ii-cpt-ii-deficiency-a-rare-cause-of-acute-kidney-injury-and-cardiomyopathy
#18
Efrain Castillo, Debbie Medina, Nick Schoenmann
Carnitine palmitoyltransferase II (CPT II) deficiency is a long-chain fatty acid (LCFA) oxidation disorder. There are three main types classified by symptoms and age of onset: the neonatal form, the infantile hepatocardiomuscular form, and the adult or myopathic form. The first two are early-onset severe disorders presenting with marked hypoketotic hypoglycemia, cardiomyopathy, and liver dysfunction. The latter is characterized by muscle pain and weakness and stiffness, typically triggered by exercise or febrile illnesses and occasionally associated with myoglobinuria...
October 2023: Curēus
https://read.qxmd.com/read/37866123/associations-between-eating-behaviors-and-metabolic-syndrome-severity-in-young-adults
#19
JOURNAL ARTICLE
Austin J Graybeal, Caleb F Brandner, Alex Henderson, Ryan A Aultman, Anabelle Vallecillo-Bustos, Ta'Quoris A Newsome, Diavion Stanfield, Jon Stavres
Metabolic syndrome (MetS), a precursor to cardiovascular disease and type II diabetes, is rapidly increasing in young adults. Accordingly, earlier interventions aimed at combating the onset of MetS in young adults are required. However, current behavioral interventions have failed to consider the eating behaviors that precede disease development, likely contributing to the consistently high failure rates of these interventions. The purpose of this cross-sectional study was to evaluate the associations between eating behaviors and MetS severity (MetSindex ) in a sample of young adults...
December 2023: Eating Behaviors
https://read.qxmd.com/read/37822389/diabetic-foot-caused-by-pancreatic-diabetes-with-adult-onset-type-ii-citrullinaemia
#20
JOURNAL ARTICLE
Tomotaka Sato, Hisashi Kobayashi, Takeyori Saheki, Daisuke Inoue
No abstract text is available yet for this article.
2023: Indian Journal of Dermatology
keyword
keyword
11090
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.